[{"arm_notes": "", "treatment_id": null, "treatment_name": "Group I (experimental): Treatment with CIGB 300 at the dose of 2.5 mg / kg; intravenously; daily for 5 days + treatment established in the national action protocol for COVID-19.Group II (control): Treatment established in the national action protocol for COVID-19.;Peptides;Administration; Intravenous;CIGB 300", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group I (experimental): Treatment with CIGB 300 at the dose of 2.5 mg / kg; intravenously; daily for 5 days + treatment established in the national action protocol for COVID-19.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group II (control): Treatment established in the national action protocol for COVID-19.;Peptides;Administration; Intravenous;CIGB 300", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 288, "treatment_name": "Cigb 300", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Group I (experimental): Treatment with CIGB 300 at the dose of 2.5 mg / kg; intravenously; daily for 5 days + treatment established in the national action protocol for COVID-19. Group II (control): Treatment established in the national action protocol for COVID-19.;Peptides;CIGB 300", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group I (experimental): Treatment with CIGB 300 at the dose of 2.5 mg / kg; intravenously; daily for 5 days + treatment established in the national action protocol for COVID-19.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group II (control): Treatment established in the national action protocol for COVID-19.;Peptides;CIGB 300", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]